Markers in the blood can predict how multiple sclerosis will develop and what drugs will be ­effective, a study found.

A collection of concert posters designed by State University professor emerita Jamie Burwell Mixon over the span of two decades is on display through early October at the Cullis Wade Depot Art Gallery ...

High-dose cholecalciferol (vitamin D) is safe and can nearly double the time it takes for clinically isolated syndrome to ...

aDementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK bDepartment of Clinical and Movement Neurosciences, Queen Square Brain Bank for Neurological ...

Villegas’ and Rodrigeuz-Hernandez’ stories are all too common in California, where the average cost of health care is the third highest in the nation.

A short course of Mavenclad can provide long-term reductions in disease activity and disability progression in highly active ...

This article examines how next-generation sequencing and state-of-the-art imaging technologies are being combined to ...

Multiple sclerosis (MS) is a disease that looks different in everyone who has it ... In 2018, the center opened a state-of-the-art infusion suite equipped with 15 infusion chairs in private and ...

Researchers have shown unprecedented control of SIV replication and decay of viral reservoirs by combining a stringent model of infection with the interruption of antiretroviral therapy (ART). The ...

Using geochemistry, scientists have identified a new blood biomarker that could help diagnose Alzheimer’s disease sooner, ...

Drug development companies are working to increase the chances of clinical success by improving biomarker identification, validation, and analysis.